CFTR and cystic fibrosis: The mechanisms by which ΔF508 disrupts CFTR folding are beginning to be understood, and small molecule modulators that restore endoplasmic reticulum (ER) trafficking and channel gating hold great promise for new treatments to correct these underlying molecular abnormalities in CF patients.